Delayed referrals, diagnoses undermine cancer patients' faith in health care system
the ONA take:
Analysis of data from a survey conducted by Cancer Research UK scientists revealed that timeliness of referral for cancer tests can have a significant impact on patients’ overall satisfaction with their care and their health care team.
Of the nearly 60,000 survey respondents whose diagnoses were made through their GPs, 23% had been seen three or more times before a referral for cancer tests was given.
Furthermore, these patients were more likely to report negative experiences across 10 of 12 different aspects of their care compared with those patients who were referred after one or two visits with their GPs.
Aspects of care in which patients were dissatisfied included the way they were informed of their diagnosis, how well hospital and GPs worked together to provide care, and confidence and trust in ward nurses.
Although diagnostic delays can be caused by the difficulty in distinguishing cancer symptoms from other diseases and a lack of accurate and easy-to-use tests, the survey results demonstrate the significance of early diagnosis on patients’ overall experience with cancer care.
The researchers report that timeliness of diagnosis is an important factor in patients’ overall experience in their cancer journey.
Timeliness of referral for cancer tests can have a significant impact on patients’ overall satisfaction.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|